Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Corticosteroids and cardioprotection

Nature Medicine volume 8, pages 453–455 (2002)Cite this article

New findings in mice suggest that corticosteroids mediate nitric oxide production in the endothelium, which in turn protects the heart against damage when deprived of oxygen. The mechanism explains, at least in part, the cardioprotective effects of these anti-inflammatory agents. (pages 473–479)

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Proposed mechanisms by which corticosteroids mediate cardioprotection.

References

  1. Libby, P., Maroko, P.R., Bloor, C.M., Sobel, B.E. & Braunwald, E. Reduction of experimental myocardial infarct size by corticosteroid administration. J. Clin. Invest. 52, 599–607 (1973).

    Article  CAS  Google Scholar 

  2. Hafezi-Moghadam, A. et al. Cardiovascular protective effects of corticosteroids mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nature Med. 8, 473–479 (2002).

    Article  CAS  Google Scholar 

  3. Hammer, H., Schoen, F.J., Braunwald, E. & Kloner, R.A. Drug-induced expansion of infarct: morphologic and functional correlations. Circulation 69, 611–617 (1984).

    Article  Google Scholar 

  4. La, M et al. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J. 15, 2247–2256 (2001).

    Article  CAS  Google Scholar 

  5. Zingarelli, B. et al. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-κB and AP-1 activation and enhances myocardial damage. FASEB J. 16, 327–342 (2002).

    Article  CAS  Google Scholar 

  6. Wayman, N.S. et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-α and PPAR-γ) reduce myocardial infarct size. FASEB J. (in the press).

  7. Zingarelli, B., Hake, P.W., Denenberg, A. & Wong, H.R. Sesquiterpene lactone parthenolide, an inhibitor of IκB kinase complex and nuclear factor-κB, exerts beneficial effects in myocardial reperfusion injury. Shock 17, 127–134 (2002).

    Article  Google Scholar 

  8. Simoncini, T. et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538–541 (2000).

    Article  CAS  Google Scholar 

  9. Hale, S.L., Birnbaum, Y. & Kloner, R.A. β-Estradiol, but not α-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am. Heart J. 132, 258–262 (1996).

    Article  CAS  Google Scholar 

  10. Rossi, A. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403, 103–108 (2000).

    Article  CAS  Google Scholar 

  11. Langdown, M.L., Holness, M.J. & Sugden, M.C. Early growth retardation induced by excessive exposure to glucocorticoids in utero selectively increases cardiac GLUT1 protein expression and Akt/protein kinase B activity in adulthood. J. Endocrinol. 169, 11–22 (2001).

    Article  CAS  Google Scholar 

  12. Dimmeler, S. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601–605 (1999).

    Article  CAS  Google Scholar 

  13. Fulton, D. et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597–601 (1999).

    Article  CAS  Google Scholar 

  14. Camper-Kirby, D. et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res. 88, 1020–1027 (2001).

    Article  CAS  Google Scholar 

  15. Lee, T.M., Su, S.F., Chou, T.F. & Tsai, C.H. Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty. J. Am. Coll. Cardiol. 39, 871–877 (2002).

    Article  Google Scholar 

  16. Kureishi, Y. et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature Med. 6, 1004–1010 (2000).

    Article  CAS  Google Scholar 

  17. Lefer, D.J. et al. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J. 15, 1454–1456 (2001).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The William Harvey Research Institute St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK

    Christoph Thiemermann

Authors
  1. Christoph Thiemermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiemermann, C. Corticosteroids and cardioprotection. Nat Med 8, 453–455 (2002). https://doi.org/10.1038/nm0502-453

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0502-453

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing